Inka Scheffrahn
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
- Oncology 8
- Peptidase Inhibition and Analysis 6
-
- Radiopharmaceutical Chemistry and Applications 6
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Björn Öbrink (5 shared papers)Bernhard B. Singer (8 shared papers)Robert Kammerer (3 shared papers)Süleyman Ergün (3 shared papers)Iris Helfrich (3 shared papers)Dirk Schadendorf (3 shared papers)Mark R. Middleton (2 shared papers)Hellmut G. Augustin (2 shared papers)
In The Last Decade
Inka Scheffrahn
13 papers receiving 808 citations
Peers
Comparison fields: 5 of 69
- Immunology and Allergy 117
- Oncology 344
- Radiology, Nuclear Medicine and Imaging 272
- Cancer Research 127
- Immunology 149
Countries citing papers authored by Inka Scheffrahn
This map shows the geographic impact of Inka Scheffrahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inka Scheffrahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inka Scheffrahn more than expected).
Fields of papers citing papers by Inka Scheffrahn
This network shows the impact of papers produced by Inka Scheffrahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inka Scheffrahn. The network helps show where Inka Scheffrahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Inka Scheffrahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 148 | |
| 2 | The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation. | 2000 | 101 |
| 3 | 2002 | 97 | |
| 4 | 2013 | 94 | |
| 5 | 2010 | 74 | |
| 6 | 2005 | 71 | |
| 7 | 2013 | 57 | |
| 8 | 2001 | 55 | |
| 9 | 1999 | 32 | |
| 10 | 2005 | 28 | |
| 11 | 2002 | 24 | |
| 12 | 2015 | 23 | |
| 13 | The CD30 ligand and CD40 ligand regulate CD54 surface expression and release of its soluble form by cultured Hodgkin and Reed-Sternberg cells. | 1996 | 17 |
About Inka Scheffrahn
Inka Scheffrahn is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology and Allergy and Pathology and Forensic Medicine, having authored 13 papers that have together received 821 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (6 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Peptidase Inhibition and Analysis (6 papers), Chemical Synthesis and Analysis (4 papers), Lymphoma Diagnosis and Treatment (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Coccidia and coccidiosis research (1 paper). The work is most often cited by research in Immunology and Allergy (117 citations), Oncology (344 citations), Radiology, Nuclear Medicine and Imaging (272 citations), Cancer Research (127 citations) and Immunology (149 citations). Inka Scheffrahn has collaborated with scholars based in Germany, Sweden and Japan. Frequent co-authors include Björn Öbrink, Bernhard B. Singer, Robert Kammerer, Süleyman Ergün, Iris Helfrich, Dirk Schadendorf, Mark R. Middleton, Hellmut G. Augustin, Kristmundur Sigmundsson and Sönke Bartling. Their work appears in journals such as The Journal of Experimental Medicine, European Journal of Immunology, The Journal of Immunology, Experimental Cell Research and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.